Pharmacomechanical hyperresponsiveness in ozone-induced airway injury.
Authors
Murlas CG
Source
NIOSH 1993 Mar; :1-6
Link
NIOSHTIC No.
20023647
Abstract
Our current research aims to determine in vivo and in vitro mechanisms which increase airway responsiveness. This has and will continue to be done in subjects with bronchial hyperreactivity, the increased airway irritability which characterizes asthma and ozone-induced lung injury. What we have learned from our previous studies of airway structure and function in this disorder suggests that injury to normal lung constituents results in the elaboration of factors leading to cholinergic neuromuscular hyperresponsiveness. Among the many potential cell types that could influence bronchomotor tone are cells of the respiratory mucosa which may affect airway muscle both pre- and post-synaptically. From our work, it appears that airway muscle responsiveness in acute, ozone-induced bronchial hyperreactivity is increased, and that this hyperresponsiveness is linked to more than one noncyclooxygenase. mucosa-derived factor in the guinea pig. Thus, we speculate that the hyperreactivity developing acutely after ozone exposure may be due to mucosa-derived factors and the cellular mechanisms by which they augment smooth muscle contractility merit further study.
Keywords
In vitro studies; In vivo studies; Bronchial asthma; Hypersensitivity; Occupational respiratory disease; Airway obstruction; Cholinergic receptors; Cell damage; Muscles; Pulmonary function; Pulmonary system disorders; Respiratory system disorders; Lung disease
Contact
Rush-Presbyterian St. Luke Medical Center, Department of Medicine (Pulmonary), 1653 W. Congress Parkway, Chicago, IL 60612
CAS No.
10028-15-6
Publication Date
19930301
Document Type
Final Grant Report
Funding Amount
127961
Funding Type
Grant
Fiscal Year
1993
Identifying No.
Grant-Number-K01-OH-00060
NIOSH Division
OEP
Priority Area
Pulmonary-system-disorders
Source Name
National Institute for Occupational Safety and Health
State
IL
Performing Organization
Rush-Presbyterian St. Luke Medical Center, Department of Medicine (Pulmonary), Chicago, IL 60612
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.